Covers novel methodologies and innovative approaches in treatment of IBD. Investigates IBD and significance of gut microbiota in progression of IBD. Investigates microbial imbalances and consequences of restoring microbial homeostasis as treatment. Explores nanotechnology and nanomedicine as treatment as well as future expansions.
Inhaltsverzeichnis
1. Introduction to Gut Microbiota and Inflammatory Bowel Disease: A Systematic Review 2. Pathogenesis of Gut Microbiota in Inflammatory Bowel Disease 3. Impact of Nutraceuticals on Gut Microbiota for the Management of Inflammatory Bowel Disease 4. Targeting Gut Microbiota with a Novel Drug Delivery System to Treat Inflammatory Bowel Disease 5. Management of Gut Microbiota-Derived Bacterial Metabolites Induced Inflammatory Bowel Disease 6. Correlation Between Host Genetics and Gut Microbiota in Inflammatory Bowel Disease 7. Oral siRNA-Based Nanomedicine for the Treatment of Inflammatory Bowel Disease 8. Site-Specific Targeted Novel Drug Delivery System for the Management of Inflammatory Bowel Disease 9. Surface-Modified Lipid Nanoparticle-Mediated Site-Specific Drug Delivery for Inflammatory Bowel Disease 10. Interplay Between Autophagy, Gut Microbiota, and Inflammatory Bowel Disease 11. Role of Reactive Oxygen Species, Superoxide Dismutases, and Inflammation in Association with Gut Microbiota and Inflammatory Bowel Disease 12. Composition of Gut Microbiota Dysbiosis and Functional Food to Treat Inflammatory Bowel Disease 13. Age-Related Gut Dysbiosis and Its Impact on Inflammatory Bowel Disease 14. Impact of Diseased Condition on Gut Microbiota in Inflammatory Bowel Disease 15. Role of Probiotics and Prebiotics in Inflammatory Bowel Disease 16. Application of Natural Products to Target Gut Microbiota for Inflammatory Bowel Disease Management 17. Future Prospects and Patents of Nanomedicines in Treating Inflammatory Bowel Disease